Literature DB >> 2684277

Studies on the degradative mechanism of phosphoenolpyruvate carboxykinase from yeast Saccharomyces cerevisiae.

N Burlini1, S Morandi, R Pellegrini, P Tortora, A Guerritore.   

Abstract

Previous work carried out in our laboratory (Burlini, N., Lamponi S., Radrizzani, M., Monti, E. and Tortora P. (1987) Biochim. Biophys. Acta 930, 220-229) led to the immunological identification of a yeast 65-kDa phosphoprotein as a modified form of phosphoenolpyruvate carboxykinase; moreover the appearance of this phospho form was proven to be independent of cAMP, whereas the glucose-induced inactivation of the native enzyme is cAMP-dependent. Here, we report further investigations on the mechanism of the glucose-triggered degradation of the enzyme which led to the following results: (a) the aforementioned phospho form displayed a binding pattern to 5 AMP-Sepharose 4B quite similar to that of native enzyme, although it did not retain its oligomeric structure, nor was it catalytically active; (b) its phosphate content was of about two residues per monomer; (c) its isoelectric point was slightly higher than that of native enzyme, this shows that the enzyme undergoes additional modifications besides phosphorylation; (d) it represented about 4% of the native enzyme in glucose-depressed cells; (e) other forms immunologically cross-reactive with the native enzyme were also isolated, whose molecular mass was in the range of 60-62 kDa, and they are probable candidates as degradation products of the phospho form; (f) time courses of the native and phospho forms in the presence and the absence of glucose provided data consistent with a kinetic model involving a strong stimulation of the decay of both forms effected by the sugar; (g) in the mutant ABYS1 (Achstetter, T., Emter, O., Ehmann, C. and Wolf, D.H. (1984) J. Biol. Chem. 259, 13334-13343) which is devoid of the four major vacuolar proteinases, the decay pattern was essentially the same as in wild-type; (h) effectors lowering intracellular ATP also retarded the first step of enzyme degradation; this points to an ATP-dependence of this step. Based on these results we propose a degradation mechanism consisting of an initial cAMP- and ATP-dependent modification of the enzyme, followed by a cAMP-independent phosphorylation, which leads to the appearance of the aforementioned monomeric phospho form; this in turn seems to undergo limited proteolysis. These data strongly suggest the occurrence of an intermediate form arising from the native one and whose phosphorylation gives rise to the 65-kDa phosphoprotein described here.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684277     DOI: 10.1016/0167-4889(89)90028-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Regulation of the acuF gene, encoding phosphoenolpyruvate carboxykinase in the filamentous fungus Aspergillus nidulans.

Authors:  Michael J Hynes; Oliver W Draht; Meryl A Davis
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

2.  Identification and characterization of regulatory elements in the phosphoenolpyruvate carboxykinase gene PCK1 of Saccharomyces cerevisiae.

Authors:  M Proft; D Grzesitza; K D Entian
Journal:  Mol Gen Genet       Date:  1995-02-06

3.  Identification of UAS elements and binding proteins necessary for derepression of Saccharomyces cerevisiae fructose-1,6-bisphosphatase.

Authors:  D Niederacher; H J Schüller; D Grzesitza; H Gütlich; H P Hauser; T Wagner; K D Entian
Journal:  Curr Genet       Date:  1992-11       Impact factor: 3.886

4.  The metabolic changes caused by dexamethasone in the adjuvant-induced arthritic rat.

Authors:  Silvana M Caparroz-Assef; Ciomar A Bersani-Amado; Ana M Kelmer-Bracht; Adelar Bracht; Emy L Ishii-Iwamoto
Journal:  Mol Cell Biochem       Date:  2007-03-09       Impact factor: 3.396

5.  CAT5, a new gene necessary for derepression of gluconeogenic enzymes in Saccharomyces cerevisiae.

Authors:  M Proft; P Kötter; D Hedges; N Bojunga; K D Entian
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.